{"url_path":"/sec/otlc/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/908259/0001493152-26-023181-index.html","accession_number":"0001493152-26-023181","cik":"0000908259","ticker":"OTLC","issuer_name":"Oncotelic Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/908259/0001493152-26-023181-index.html","primary_entity_key":"0000908259","primary_entity_name":"Oncotelic Therapeutics, Inc."},"word_count":51,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nFrom\ntime to time, we may become involved in legal proceedings arising in the ordinary course of our business. Historically, the outcome of\nall such legal proceedings has not, in the aggregate, had a material adverse effect on our business, financial condition, results of\noperations or liquidity."}